Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.
Published May 20, 2026 · Recall initiated: March 13, 2026
Summary
FDA records drug Class II recall D-0527-2026, published May 20, 2026 and initiated March 13, 2026. Recalling firm: ENDO USA, Inc.; Status: Ongoing; Reported quantity: 34,293 vials; Lot: Lot #: 84132, Exp 02/28/2027; 87693, Exp 03/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Crystallization; identified as Buprenorphine free base
What to do
Voluntary: Firm initiated · Letter
Get an email if BUPRENORPHINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BUPRENORPHINE HYDROCHLORIDE
- Manufacturer
- ENDO USA, Inc.
- Distributor
- USA Nationwide
- Lot
- Lot #: 84132, Exp 02/28/2027; 87693, Exp 03/31/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABuprenorphine Hydrochloride, Injection 0.3 mg/mL, Rx Only, 5 x 1 mL Single Dose Vials, Manufactured for: EndoOctober 7, 2026
- FDABuprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, ForJune 24, 2026
- FDAOasis Tears PF, Preservative-Free Lubricant Eye Drops, 10mL/0.34 Fl OZ Bottle, Sterile, Manufactured for:May 20, 2026
- FDAAscend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by:May 20, 2026
- FDABuprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge Unit withJuly 3, 2024
- FDABuprenorphine HCl, Injection, 0.3mg/mL, For Intramuscular or Intravenous Use, Rx Only, 1mL Single Dose Vial,November 15, 2023
Questions about this recall
Was Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05. recalled?
Yes. FDA published recall D-0527-2026 on May 20, 2026. Reported hazard: Crystallization; identified as Buprenorphine free base
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BUPRENORPHINE HYDROCHLORIDE.